| Autor: |
Dubey, Vishal, Kansagra, Jignesh, Sureja, Varun, Kheni, Dharmeshkumar |
| Zdroj: |
Future Journal of Pharmaceutical Sciences; December 2024, Vol. 10 Issue: 1 |
| Abstrakt: |
Background: Diabetes is one of the most prevalent metabolic diseases with high rate of morbidity and mortality. The increased level of blood glucose level and increased insulin resistance is the hallmark of diabetes. Currently, various non-pharmacological and pharmacological therapeutic options are used for lowering the glucose level and improving the insulin activity. The current systematic review and meta-analysis study was conducted to evaluate the efficacy of Berberis aristataand Silybum marianumfixed dose nutraceutical combination on serum glucose and glycated haemoglobin level and insulin resistance parameters. Main Body: Randomized controlled trials, identified from three online databases, evaluating the efficacy of Berberis aristataand Silybum marianumfixed dose combination were identified and evaluated as per pre-defined protocol. Quality of studies was evaluated using PEDro scale, and risk of bias was assessed using Cochrane Risk of Bias Tool. Pooled effect was reported as mean difference (MD) and 95% confidence interval, while the complete study was conducted as per PRISMA and Cochrane guidelines. After complete literature screening and evaluation process, seven studies were included in the final analysis. Data of 825 participants (active group: 416 participants and control group: 409 participants) were utilized for the statistical analysis. All included studies (except one) were of good quality. Supplementation of fixed dose combination significantly reduced glucose level (MD: − 5.26 mg/dl; p= 0.02) and glycated haemoglobin (HbA1c) level (MD: − 0.69%; p< 0.0001) as compared to control therapy, while greater insulin resistance reduction was observed in active group and the difference approached significance (MD: − 0.64 HOMA-IR score; p= 0.08). Risk of bias analysis revealed some concerns regarding biasness (mainly due to randomization, outcome measurement and selected reporting biasness). All included studies had moderate risk of biasness. Sensitivity analysis revealed effect of particular study on overall heterogeneity observed, while neither significant publication bias nor any missing study was observed. Conclusion: The results of current study suggest that B. aristataand S. marianumfixed dose combination is effective in improving glycaemic and insulin parameters and can be effective in diabetic population. The observed sensitivity of certain studies on overall heterogeneity and the moderate risk of biasness warrants further well-designed clinical studies to strengthen the results of current study. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Full text from SpringerLink